TrialThe journal of headache and pain2026

Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trial.

Henrik W Schytz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.